PIK3CD and neoplasm: Regarding the potential implication of the different isoforms of PI3K within the various stromal cells involved in tumor progression, Niedermeier et al. identified that p110α-specific inhibitors could counteract the chemoresistance shown by chronic lymphoid leukemia, by suppressing the protective effect of marrow stromal cells on fludarabine-induced apoptosis [29].